|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.75 SEK | +1.85% |
|
+14.58% | +72.96% |
| Apr. 25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Jan. 29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Arcoma AB reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was SEK 117.13 million compared to SEK 117.42 million a year ago. Revenue was SEK 117.97 million compared to SEK 117.91 million a year ago.
Net loss was SEK 7.47 million compared to net income of SEK 1.44 million a year ago. Basic loss per share from continuing operations was SEK 0.57 compared to basic earnings per share from continuing operations of SEK 0.12 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +72.96% | 16.24M | |
| -5.77% | 14.6B | |
| -40.71% | 2.71B | |
| -12.92% | 2.44B | |
| -8.78% | 1.51B | |
| -.--% | 1.12B | |
| +40.66% | 518M | |
| +11.68% | 239M | |
| +1.67% | 183M | |
| -.--% | 168M |
ARCOMA AB 
